You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

  • Technology appraisal guidance
  • Reference number: TA341
  • Published:  04 June 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document
06 March 2015
(384.84 Kb 52 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 04 March 2015

Back to top